Risk of sequelae after chlamydia trachomatis genital infection in women

Journal of Infectious Diseases

Volumn 201, Issue SUPPL. 2, 2010, Pages

  Haggerty, Catherine L ^a   Gottlieb, Sami L ^b   Taylor, Brandie D ^a   Low, Nicola ^d   Xu, Fujie ^b   Ness, Roberta B ^c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; PENICILLIN G; PROBENECID; TETRACYCLINE;

CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; DISEASE COURSE; ECTOPIC PREGNANCY; ENDOMETRITIS; FEMALE INFERTILITY; GENITAL TRACT INFECTION; HUMAN; INFECTION RISK; MEDICAL EXAMINATION; MORBIDITY; PELVIC INFLAMMATORY DISEASE; PRIORITY JOURNAL; REVIEW; SALPINGITIS; FEMALE; GYNECOLOGIC DISEASE; INFERTILITY; PATHOLOGY; PHYSIOLOGY; PREGNANCY; RECURRENT DISEASE; RISK FACTOR;

CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; GENITAL DISEASES, FEMALE; HUMANS; INFERTILITY; PREGNANCY; PREGNANCY, ECTOPIC; RECURRENCE; RISK FACTORS;

EID: 77953099410     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/652395     Document Type: Review

References (76)

1. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance, 2007. Atlanta, GA: US Department of Health and Human Services, 2008.
2. Brunham RC, Binns B, Guijon F, et al. Etiology and outcome of acute pelvic inflammatory disease. J Infect Dis 1988; 158(3): 510-517.
3. Chow JM, Yonekura ML, Richwald GA, Greenland S, Sweet RL, Schachter J. The association between Chlamydia trachomatis and ectopic pregnancy: a matched-pair, case-control study. JAMA 1990; 263(23): 3164-3167.
4. Ness RB, Soper DE, Richter HE, et al. Chlamydia antibodies, chlamydia heat shock protein, and adverse sequelae after pelvic inflammatory disease: the PID Evaluation and Clinical Health (PEACH) Study. Sex Transm Dis 2008; 35(2): 129-135.
5. Robertson JN, Ward ME, Conway D, et al. Chlamydial and gonococcal antibodies in sera of infertile women with tubal obstruction. J Clin Pathol 1987; 40(4): 377-383. (Pubitemid 17046176)
6. Stamm WE. Chlamydia trachomatis infections in the adult. In: Holmes KK, Sparling PF, Stamm WE, et al, eds. Sexually transmitted diseases. New York: McGraw Hill Medical, 2008: 575-594.
7. Westrom L, Joesoef R, Reynolds G, Hagdu A, Thompson SE. Pelvic inflammatory disease and fertility: a cohort study of 1, 844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 1992; 19(4): 185-192.
8. Rein DB, Kassler WJ, Irwin KL, Rabiee L. Direct medical cost of pelvic inflammatory disease and its sequelae: decreasing, but still substantial. Obstet Gynecol 2000; 95(3): 397-1102 (Pubitemid 30100506)
9. Washington AE, Katz P. Cost and payment source for pelvic inflammatory disease: trends and projections, 1983 through 2000. JAMA 1991; 266: 2565-2569.
10. Westrom L. Decrease in incidence of women treated in hospital for acute salpingitis in Sweden. Genitourin Med 1988; 64(1): 59-63. (Pubitemid 18082123)
11. Paavonen J, Westrom L, Eschenbach DA. Pelvic inflammatory disease. In: Holmes KK, Sparling PF, Stamm WE, et al., eds. Sexually transmitted diseases. New York: McGraw Hill Medical, 2008: 1017-1050.
12. Haggerty CL, Hillier SL, Bass DC, Ness RB. Bacterial vaginosis and anaerobic bacteria are associated with endometritis. Clin Infect Dis 2004; 39(7): 990-995.
13. Haggerty CL. Evidence for a role of Mycoplasma genitalium in pelvic inflammatory disease. Curr Opin Infect Dis 2008; 21(1):65-69.
14. Hillier SL, Kiviat NB, Hawes SE, et al. Role of bacterial vaginosisassociated microorganisms in endometritis. Am J Obstet Gynecol 1996;175(2): 435-1141
15. Ness RB, Soper DE, Holley RL, et al. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the PID Evaluation and Clinical Health (PEACH) randomized trial. Am J Obstet Gynecol 2002; 186(5): 929-937.
16. Ness RB, Kip KE, Hillier SL, et al. A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease. Am J Epidemiol 2005; 162(6):585-590.
17. Simms I, Eastick K, Mallinson H, et al. Associations between Mycoplasma genitalium, Chlamydia trachomatis and pelvic inflammatory disease. J Clin Pathol 2003; 56(8): 616-618.
18. Heinonen PK, Miettinen A. Laparoscopic study on the microbiology and severity of acute pelvic inflammatory disease. Eur J Obstet Gynecol Reprod Biol 1994; 57(2): 85-89.
19. Ness RB, Randall H, Richter HE, et al. Condom use and the risk of recurrent pelvic inflammatory disease, chronic pelvic pain, or infertility following an episode of pelvic inflammatory disease. Am J Public Health 2004; 94(8): 1327-1329. (Pubitemid 39006802)
20. Haggerty CL, Ness RB, Amortegui A, et al. Endometritis does not predict reproductive morbidity after pelvic inflammatory disease. Am J Obstet Gynecol 2003; 188(1): 141-148. (Pubitemid 36135610)
21. Bevan CD, Johal BJ, Mumtaz G, Ridgway GL, Siddle NC. Clinical, laparoscopic and microbiological findings in acute salpingitis: report on a United Kingdom cohort. Br J Obstet Gynaecol 1995; 102(5): 407-414.
22. Eckert LO, Hawes SE, Wolner-Hanssen PK, et al. Endometritis: the clinical-pathologic syndrome. Am J Obstet Gynecol 2002; 186(4): 690-695.
23. Eckert LO, Thwin SS, Hillier SL, Kiviat NB, Eschenbach DA. The antimicrobial treatment of subacute endometritis: a proof of concept study. Am J Obstet Gynecol 2004; 190(2):305-313.
24. Wiesenfeld HC, Hillier SL, Krohn MA, et al. Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease. Obstet Gynecol 2002; 100(3):456-463.
25. Wiesenfeld HC, Sweet RL, Ness RB, Krohn MA, Amortegui AJ, Hillier SL. Comparison of acute and subclinical pelvic inflammatory disease. Sex Transm Dis 2005;32(7):400-405. (Pubitemid 40875375)
26. Safrin S, Schachter J, Dahrouge D, Sweet RL. Long-term sequelae of acute pelvic inflammatory disease: a retrospective cohort study. Am J Obstet Gynecol 1992; 166(4):1300-1305.
27. Stacey CM, Munday PE, Taylor-Robinson D, et al. A longitudinal study of pelvic inflammatory disease. Br J Obstet Gynaecol 1992;99(12): 994-999.
28. Buchan H, Vessey M, Goldacre M, Fairweather J. Morbidity following pelvic inflammatory disease. Br J Obstet Gynaecol 1993; 100(6): 558-562. (Pubitemid 23186360)
29. Lepine LA, Hillis SD, Marchbanks PA, Joesoef MR, Peterson HB, Westrom L. Severity of pelvic inflammatory disease as a predictor of the probability of live birth. Am J Obstet Gynecol 1998; 178(5):977-981. (Pubitemid 28247173)
30. Brunham RC, Rekart ML. The arrested immunity hypothesis and the epidemiology of chlamydia control. Sex Transm Dis 2008;35(1):53-54.
31. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2007 supplement: chlamydia prevalence monitoring project annual report 2007. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2009.
32. Gottlieb SL, Brunham R, Byrne GI, Martin DH, Xu F, Berman SM. Introduction: the natural history and immunobiology of Chlamydia trachomatis genital infection and implications for chlamydia control. J Infect Dis 2010;201 (Suppl 2):S85-S87 (in this supplement).
33. Hosenfeld CB, Workowski KA, Berman S, et al. Repeat infection with chlamydia and gonorrhea among females: a systematic review of the literature. Sex Transm Dis 2009;36(8):478-489.
34. Bachmann LH, Richey CM, Waites K, Schwebke JR, Hook EW III. Patterns of Chlamydia trachomatis testing and follow-up at a University Hospital Medical Center. Sex Transm Dis 1999;26(9):496-1299
35. Geisler WM, Wang C, Morrison SG, Black CM, Bandea CI, Hook EW III. The natural history of untreated Chlamydia trachomatis infection in the interval between screening and returning for treatment. Sex Transm Dis 2008; 35(2):119-123.
36. Hook EW, III, Spitters C, Reichart CA, Neumann TM, Quinn TC. Use of cell culture and a rapid diagnostic assay for Chlamydia trachomatis screening. JAMA 1994;272(11):867-870.
37. Morre SA, van den Brule AJ, Rozendaal L, et al. The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow-up. Int. J STD AIDS 2002; 13(Suppl 2):12-18.
38. Rahm VA, Belsheim J, Gleerup A, Gnarpe H, Rosen G. Asymptomatic carriage of Chlamydia trachomatis: a study of 109 teenage girls. Eur J Sex Transm Dis 1986;3:91-94.
39. Stamm WE, Guinan ME, Johnson C, Starcher T, Holmes KK, McCormack WM. Effect of treatment regimens for Neisseria gonorrhoeae on simultaneous infection with Chlamydia trachomatis. N Engl J Med 1984;310(9):545-549.
40. Heinonen PK, Leinonen M.. Fecundity and morbidity following acute pelvic inflammatory disease treated with doxycydine and metronidazole. Arch Gynecol Obstet 2003;268(4):284-288. (Pubitemid 37210331)
41. Haggerty CL, Peipert JF, Weitzen S, et al. Predictors of chronic pelvic pain in an urban population of women with symptoms and signs of pelvic inflammatory disease. Sex Transm Dis 2005;32(5):293-299. (Pubitemid 40578069)
42. Hillis SD, Joesoef R, Marchbanks PA, Wasserheit JN, Cates W Jr, Westrom L. Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility. Am J Obstet Gynecol 1993; 168(5):1503-1509. (Pubitemid 23153297)
43. Low N, Egger M, Sterne JA, et al. Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: the Uppsala Women's Cohort Study. Sex Transm Infect 2006; 82(3):212-218. (Pubitemid 43901588)
44. Ness RB, Smith KJ, Chang CC, Schisterman EF, Bass DC. Prediction of pelvic inflammatory disease among young, single, sexually active women. Sex Transm Dis 2006; 33(3): 137-142.
45. Bakken IJ, Skjeldestad FE, Lydersen S, Nordbo SA. Births and ectopic pregnancies in a large cohort of women tested for Chlamydia trachomatis. Sex Transm Dis 2007;34(10):739-743.
46. Hillis SD, Owens LM, Marchbanks PA, Amsterdam LF, Mac Kenzie WR. Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease. Am J Obstet Gynecol 1997; 176:103-107.
47. Kimani J, Maclean IW, Bwayo JJ, et al. Risk factors for Chlamydia trachomatis pelvic inflammatory disease among sex workers in Nairobi, Kenya. J Infect Dis 1996;173(6):1437-1444.
48. Centers for Disease Control and Prevention. Infertility Prevention Program, USA. http://www.cdc.gov/std/infertility/ipp.htm. Accessed 10 November 2009.
49. Brunham RC, Maclean IW, Binns B, Peeling RW Chlamydia trachomatis: its role in tubal infertility. J Infect Dis 1985; 152(6):1275-1282.
50. Miettinen A, Heinonen PK, Teisala K, Hakkarainen K, Punnonen R. Serologic evidence for the role of Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma hominis in the etiology of tubal factor infertility and ectopic pregnancy. Sex Transm Dis 1990; 17(1):10-14.
51. Toye B, Laferriere C, Claman P, Jessamine P, Peeling R. Association between antibody to the chlamydial heat-shock protein and tubal infertility. J Infect Dis 1993;168(5):1236-1240. (Pubitemid 23317141)
52. World Health Organization Task Force on the Prevention and Management of Infertility. Tubal infertility: serologic relationship to past chlamydial and gonococcal infection. Sex Transm Dis 1995;22(2): 71-77.
53. Brunham RC, Peeling R, Maclean I, Kosseim ML, Paraskevas M. Chlamydia trachomatis-associated ectopic pregnancy: serologic and histologic correlates. J Infect Dis 1992;165(6):1076-1081.
54. Sziller I, Witkin SS, Ziegert M, Csapo Z, Ujhazy A, Papp Z. Serological responses of patients with ectopic pregnancy to epitopes of the Chlamydia trachomatis 60 kDa heat shock protein. Hum Reprod 1998; 13(4):1088-1093.
55. Paavonen J, Aine R, Teisala K, Heinonen PK, Punnonen R. Comparison of endometrial biopsy and peritoneal fluid cytologic testing with laparoscopy in the diagnosis of acute pelvic inflammatory disease. Am J Obstet Gynecol 1985; 151(5):645-650. (Pubitemid 15049698)
56. Paavonen J, Teisala K, Heinonen PK, et al. Microbiological and histopathological findings in acute pelvic inflammatory disease. Br J Obstet Gynaecol 1987; 94:454-460. (Pubitemid 17068096)
57. Wasserheit JN, Bell TA, Kiviat NB, et al. Microbial causes of proven pelvic inflammatory disease and efficacy of clindamycin and tobramycin. Ann Intern Med 1986;104(2):187-193.
58. Short VL, Totten PA, Ness RB, et al. Clinical presentation of Mycoplasma genitalium infection versus Neisseria gonorrhoeae infection among women with pelvic inflammatory disease. Clin Infect Dis 2009;48(1):41-47.
59. Wolner-Hanssen P. Silent pelvic inflammatory disease: is it overstated? Obstet Gynecol 1995;86(3):321-325.
60. Patton DL, Moore DE, Spadoni LR, Soules MR, Halbert SA, Wang SP. A comparison of the fallopian tube's response to overt and silent salpingitis. Obstet Gynecol 1989;73(4):622-630.
61. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. MMWR Morbid Mortal Wkly Rep 2006; 55:1-94.
62. Molander P, Finne P, Sjoberg J, Sellors J, Paavonen J. Observer agree- ment with laparoscopic diagnosis of pelvic inflammatory disease using photographs. Obstet Gynecol 2003;101:875-880. (Pubitemid 36561247)
63. Sellors J, Mahony J, Goldsmith C, et al. The accuracy of clinical findings and laparoscopy in pelvic inflammatory disease. Am J Obstet Gynecol 1991;164:113-120.
64. Tukeva TA, Aronen HJ, Karjalainen PT, Molander P, Paavonen T, Paavonen J. MR imaging in pelvic inflammatory disease: comparison with laparoscopy and US. Radiology 1999;210(1 ):209-216. (Pubitemid 29004306)
65. Boardman LA, Peipert JF, Brody JM, Cooper AS, Sung J. Endovaginal sonography for the diagnosis of upper genital tract infection. Obstet Gynecol 1997;90(1):54-57. (Pubitemid 27272956)
66. Molander P, Sjoberg J, Paavonen J, Cacciatore B. Transvaginal power Doppler findings in laparoscopically proven acute pelvic inflammatory disease. Ultrasound Obstet Gynecol 2001; 17(3):233-238. (Pubitemid 32336766)
67. Peipert JF, Boardman L, Hogan JW, Sung J, Mayer KH. Laboratory evaluation of acute upper genital tract infection. Obstet Gynecol 1996;87:730-736. (Pubitemid 26127092)
68. Aghaizu A, Atherton H, Mallinson H, et al. Incidence of pelvic inflammatory disease in untreated women infected with Chlamydia trachomatis. Int J STD AIDS 2008; 19(4):283.
69. Oakeshott P, Kerry S, Atherton H, et al. Community-based trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. Trials 2008; 9: 73.
70. Oakeshott P, Kerry S, Aghaizu A, et al. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. BMJ 2010; 340: e1642.
71. Gottlieb SL, Berman SM, Low N. Screening and treatment to prevent sequelae in women with Chlamydia trachomatis genital infection: how much do we know? J Infect Dis 2010;201(Suppl 2):S156-S167 (in this supplement).
72. Wiesenfeld H, Sumkin J, Amortegui A, Hillier S.L., Krohn MA, Sweet RL. Subclinical pelvic inflammatory disease (PID) is associated with fallopian tube damage. In: Program and abstracts of the 17th Meeting of the International Society for STD Research (Seattle). 2007. Abstract 0-O53.
73. Darville T, Hiltke T. Pathogenesis of genital tract disease due to Chlamydia trachomatis. J Infect Dis 2010;201(Suppl 2):S114-S125 (in this supplement).
74. Haggerty CL, Totten PA, Astete SG, et al. Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease. Sex Transm Infect 2008;84(5):338-342.
75. Burstein GR, Zenilman JM, Gaydos CA, et al. Predictors of repeat Chlamydia trachomatis infections diagnosed by DNA amplification testing among inner city females. Sex Transm Infect 2001;77(1):26-32.
76. Niccolai LM., Hochberg AL, Ethier KA, Lewis JB, Ickovics JR. Burden of recurrent Chlamydia trachomatis infections in young women: further uncovering the "hidden epidemic." Arch Pediatr Adolesc Med 2007; 161(3):246-251.